Methods A prospective cohort of 212 patients with COPD was monitored using daily symptom diaries for a median of 2.8 years to characterise the time course of COPD exacerbation onset. Decision rules ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Hospital admission and emergency department attendances for COPD exacerbations were recorded over a 3-month period and analysed on an intention-to-treat basis. Secondary outcomes included exercise ...

A clinically and functionally relevant definition of an asthma exacerbation will be invaluable in the assessment of the severity of such an event and the streamlining of the steps necessary to ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

The use of systemic corticosteroids during exacerbation decreased treatment failure rate by 46% and was associated with a mean decrease in hospital length of stay by 1.42 days when compared with ...

In a Q&A, Peter Monti, a professor of alcohol and addiction studies at Brown University and a leading researcher of alcohol ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

A study investigates sparkling water's role in weight loss, suggesting it might enhance glucose metabolism similar to effects ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

Thiazolidinedione use was associated with lower risk for mortality and cardiorenal events among adults with type 2 diabetes and acute kidney disease.